Matinas BioPharma Holdings Inc. (MTNB) PT Lowered to $3 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts MTNB Hot Sheet
Price: $0.90 +1.12%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Trade Now!
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Matinas BioPharma Holdings Inc. (NYSE: MTNB) to $3.00 (from $4.00) while maintaining a Buy rating.
You May Also Be Interested In
- Honda Motor Co Ltd (7267:JP) (HMC) PT Raised to JPY3,950 at Credit Suisse
- Seven Group Holdings Limited (SVW:AU) (SVNWF) PT Raised to AUD27.50 at Credit Suisse
- Tata Steel Ltd (TTST:LI) PT Raised to INR1,250 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
